Chime Partners with Dubb to Bring Power of Video to Lead Engagement and Conversion
Seamless integration provides real estate professionals with an easy way to build trust, differentiate themselves,…
Month: November 2021
Zai Lab Announces First Patient Dosed in Greater China in Global Registrational Clinical Trial of Efgartigimod in CIDP
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) — Zai Lab…
Verizon introduces hands-free calling via Alexa at Home
“Alexa, answer the call.” Verizon’s New Number Share lets you use your mobile number for…
Todos Medical’s Provista Laboratory to Boost Top Line Through New Atlanta-based Reference Lab Agreement for COVID PCR, cPass Neutralizing Antibody & Respiratory Pathogen Panel Tests
New York, NY, and Tel Aviv, ISRAEL, Nov. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos…
BioCorRx Provides Business Update for the Third Quarter of 2021
ANAHEIM, CA, Nov. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
The European Commission Grants Marketing Authorization for VUMERITY® (diroximel fumarate) as Oral Treatment for Relapsing-Remitting Multiple Sclerosis
VUMERITY is a next-generation oral fumarate treatment for people with relapsing-remitting MS with established efficacy…
Cosmos Holdings Achieves Positive Adjusted Net Income and Positive Adjusted EBITDA for the Third Quarter of 2021
CHICAGO, Nov. 16, 2021 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM), an…
Biofrontera Kicks Off US Clinical Study Program for Ameluz®
WOBURN, MA, Nov. 16, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a…
PacBio Launches HiFiViral SARS-CoV-2 Kit and Microbial Whole Genome Sequencing Enhancements to Combat Infectious Disease and Strengthen Public Health Response to Pathogen Threats
Robust SARS-CoV-2 sequencing kit and upgraded microbial whole genome assembly workflow enable public health laboratories…
AXIM Biotechnologies Partners with Arizona State University to Determine Antibody Levels Against COVID-19
Company develops COVID-19 “Correlate of Protection” research to measure levels of neutralizing antibodies which protect…
Morphic Announces Participation in Upcoming Investor Conferences
WALTHAM, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing…
Hepion Pharmaceuticals and FibroFind Announce Anti-Cancer Activity of CRV431 in a Nonclinical Liver Cancer Study
EDISON, N.J., Nov. 16, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Recommends Approval of Tecovirimat
– Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications – NEW YORK, Nov….
Rakovina Therapeutics Partners with St. Baldrick’s Foundation to Research and Develop New Treatments for Childhood Bone Cancer
VANCOUVER, British Columbia, Nov. 16, 2021 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (“the…
CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes
-Initiation of patient enrollment expected by year-end- ZUG, Switzerland and CAMBRIDGE, Mass. and SAN DIEGO,…
VistaGen Therapeutics to Present at the Jefferies London Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (NASDAQ: VTGN),…
Oncotelic Announces Successful Completion of the Safety Evaluation of a TGF-β Inhibitor (OT-101) and IL-2 (Aldesleukin) in Phase 1 Combination Trial in Solid Tumor Cancers
AGOURA HILLS, CA, Nov. 16, 2021 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the…
Optinose Announces Pricing of Public Offering of Common Stock
YARDLEY, Pa., Nov. 16, 2021 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on…
Abyssinia Biologics Debuts Data on Ultra-sensitive Plasma Immunoassay for Key Synaptotoxin in Alzheimer’s Disease Pathogenesis
Assay developed using Abyssinia proprietary antibodies shows promise as sensitive and specific companion diagnostic Further…
AGTC Appoints Abraham Scaria, Ph.D., as Chief Science Officer
With 25+ years of experience, Dr. Scaria has led numerous gene therapy programs from early…